1286278-43-0

Basic information

• Product Name: C₁₄H₁₅N₅O₃S
• Synonyms: C₁₄H₁₅N₅O₃S
• CAS NO: 1286278-43-0
• Molecular Weight: 333.371
• Mol File: 1286278-43-0.mol

Chemical Properties

• CAS DataBase Reference: C₁₄H₁₅N₅O₃S(CAS DataBase Reference)
• NIST Chemistry Reference: C₁₄H₁₅N₅O₃S(1286278-43-0)
• EPA Substance Registry System: C₁₄H₁₅N₅O₃S(1286278-43-0)

Safety Data

• Hazardous Substances Data: 1286278-43-0(Hazardous Substances Data)

Upstream product

• 1286278-42-9 C₁₃H₁₃N₅O 
• 124-63-0 methanesulfonyl chloride 
• 1286278-41-8 5-amino-1-(2-hydroxyethyl)-3-phenyl-1H-pyrazole-4-carbonitrile 
• 42754-56-3 2-(methoxyphenylmethylene)malononitrile 
• 5515-36-6 α-cyano-β-hydroxycinnamonitrile 
• 98-88-4 benzoyl chloride 
• 42754-69-8 4-Amino-3-phenylpyrazolo<3,4-d>pyrimidine 

Downstream Products

• 1286278-44-1 1-(2-azidoethyl)-3-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine 
• 1286278-48-5 1-(2-(4-butyl-1H-1,2,3-triazol-1-yl)ethyl)-3-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine 
• 1286278-49-6 1-(2-(4-hexyl-1H-1,2,3-triazol-1-yl)ethyl)-3-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine 
• 1286278-50-9 1-(2-(4-heptyl-1H-1,2,3-triazol-1-yl)ethyl)-3-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine 
• 1286278-51-0 1-(2-(4-decyl-1H-1,2,3-triazol-1-yl)ethyl)-3-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine 
• 1286278-52-1 1-(2-(4-benzyl-1H-1,2,3-triazol-1-yl)ethyl)-3-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine 
• 1286278-53-2 1-(2-(4-(4-methoxyphenyl)-1H-1,2,3-triazol-1-yl)ethyl)-3-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine 
• 1286278-54-3 1-(2-(4-(4-fluorophenyl)-1H-1,2,3-triazol-1-yl)ethyl)-3-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine 
• 1286278-55-4 1-(4-(1-(2-(4-amino-3-phenyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-1H-1,2,3-triazol-4-yl)phenyl)ethanone 
• 1286278-56-5 1-(2-(4-(3-chloropropyl)-1H-1,2,3-triazol-1-yl)ethyl)-3-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine 

Relevant articles and documents

Development of the phenylpyrazolo[3,4-d]pyrimidine-based, insulin-like growth factor receptor/Src/AXLtargeting small molecule kinase inhibitor

Rationale: The type I insulin-like growth factor receptor (IGF-1R) signaling pathway plays key roles in the development and progression of numerous types of human cancers, and Src and AXL have been found to confer resistance to anti-IGF-1R therapies. Henc

Synthesis of 3-phenylpyrazolopyrimidine-1,2,3-triazole conjugates and evaluation of their Src kinase inhibitory and anticancer activities

A series of two classes of 3-phenylpyrazolopyrimidine-1,2,3-triazole conjugates were synthesized using click chemistry approach. All compounds were evaluated for inhibition of Src kinase and human ovarian adenocarcinoma (SK-Ov-3), breast carcinoma (MDA-MB